Alex Hirsh, MD
Dermatology · Cleveland, OHNPI 1174639181
Payments from drug & device makers
Across 424 payments — averaging $375.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$129K
- Lilly USA, LLC$27K
- AbbVie$688
- Amgen$260
- Sun Pharmaceutical Industries Inc.$254
- Johnson & Johnson$226
- plus $2K from 28 others
What the payments were for
- Consulting fees$1,0001%
- Speaking & faculty fees$141,71089%
- Travel & lodging$6,0514%
- Food & beverage$10,1786%
- Education$1130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 191 | $129,363 |
| Lilly USA, LLC | 68 | $26,506 |
| AbbVie | 35 | $688 |
| Amgen | 13 | $260 |
| Sun Pharmaceutical Industries Inc. | 14 | $254 |
| Johnson & Johnson | 8 | $226 |
| Incyte Corporation | 10 | $206 |
| Dermavant Sciences, Inc. | 13 | $177 |
| LEO Pharma Inc. | 8 | $174 |
| Almirall LLC | 6 | $109 |
| Pfizer | 7 | $109 |
| UCB, Inc. | 4 | $102 |
| E.r. Squibb & Sons, L.L.C. | 5 | $95 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $90 |
| Novartis | 5 | $88 |
| Boehringer Ingelheim | 4 | $84 |
| EPI Health, LLC | 3 | $63 |
| Dermira, Inc. | 3 | $63 |
| Organon | 2 | $51 |
| Arcutis Biotherapeutics, Inc. | 3 | $49 |
| Sanofi | 2 | $43 |
| Prugen, Inc. Pharmaceuticals | 2 | $39 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| LNHC, Inc | 1 | $25 |
| Bristol Myers Squibb | 1 | $25 |
| VYNE Pharmaceuticals Inc. | 1 | $21 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Journey Medical Corporation | 1 | $15 |
| Qiagen, LLC | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Biofrontera Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$159,052 in reported general payments places this provider in the 90th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $92,279 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $86,900 |
| Clobetasol Propionate | 240 | $12,177 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 11 | $7,380 |
| Doxycycline Hyclate | 228 | $5,606 |
| Ivermectin | 18 | $4,719 |
| Metronidazole | 106 | $4,233 |
| Alclometasone Dipropionate | 64 | $3,642 |
| Clindamycin Phosphate | 68 | $3,125 |
| Ketoconazole | 196 | $2,821 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 111 | $2,745 |
| Triamcinolone Acetonide | 176 | $2,739 |
| Pimecrolimus | 12 | $2,226 |
| ValacyclovirValacyclovir Hcl | 36 | $1,784 |
| Tacrolimus | 22 | $1,701 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cleveland
- Neil KormanCleveland$6M
- Anthony FernandezCleveland$1.4M
- Wilma BergfeldCleveland$642K
- Shilpi KhetarpalCleveland$383K
- Edward MaytinCleveland$190K
- Mara Weinstein VelezCleveland$129K
- Samantha PollyCleveland$80K
- Matthew ZirwasBexley$7.4M
- Jeffrey TraversDayton$4.7M
- Jennifer NashWesterville$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.